Description:

AMC-045 Chemistries, LFT's (F23) Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer https://clinicaltrials.gov/ct2/show/NCT00324415

Link:

https://clinicaltrials.gov/ct2/show/NCT00324415

Keywords:

8/26/12 8/26/12 -
6/9/17 6/9/17 - Martin Dugas

Uploaded on:

June 9, 2017

DOI:

To request one please log in.

License :

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

HIV Anal Cancer Therapy NCT00324415 AMC-045

Details

No Instruction available.

1 forms

StudyEvent: AMC-045 Chemistries, LFT's (F23)
1. No Instruction available.

Header Module

Visit number

Sequence number

Date of evaluation

mm/dd/yyyy

Reporting Period (select one)

Baseline (Baseline)

On Treatment (On treatment)

Post-therapy (Post therapy)

Comments

Ccrr Module For Chemistries, Lft's - Rf23

Sodium (mEq/L)

mmol/L

Potassium (mEq/L)

mmol/L

Chloride (mEq/L)

mEq/L

Magnesium

mmol/L

Bicarbonate (mEq/L)

mEq/L

Alkaline Phosphatase (mU/ml)

SGOT (AST)

mU/ml

SGPT (ALT)

mU/ml

BUN

mg/dl

Creatinine

mg/dL

Total Bilirubin

mg/dl

Indirect Bilirubin

mg/dl

Albumin

g/dl

Other, specify test

Back to the top of the page

Similar models

Show recommended models

Description:

Link:

Keywords:

Versions (2)

Uploaded on:

DOI:

License :

Model comments :

Itemgroup comments for :

Item comments for :

HIV Anal Cancer Therapy NCT00324415 AMC-045

No Instruction available.

Similar models

Contact

Help